Merck scraps £1bn expansion in the UK over lack of state investment The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.

#pharmaindustry #lifesciences #MSD #Medicine #Pharmaceuticalindustry #UKeconomy #pharmaceuticalcompanies #NHS #NHSmedicinesspending #healthcarespend #ABPI #AstraZeneca #cuttingedgetreatments #Norvartis #DepartmentofIndustryScienceandTechnology #NHSinnovation
www.bbc.co.uk/news/article...